Cardiovascular risk management requires a combination of cardiovascular preventive pharmacotherapy and non-pharmacological interventions

This publication has 8 references indexed in Scilit:

• Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
  The Lancet, 2021
• Underuse of cardiovascular preventive pharmacotherapy could be compensated by lifestyle-measures
  European Journal of Preventive Cardiology, 2021
• Cardiovascular preventive pharmacotherapy stratified by predicted cardiovascular risk: a national data linkage study
  European Journal of Preventive Cardiology, 2021
• Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders
  International Journal of Epidemiology, 2018
• A systematic review of patient reported factors associated with uptake and completion of cardiovascular lifestyle behaviour change
  BMC Cardiovascular Disorders, 2012
• Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16
  European Journal of Preventive Cardiology, 2012
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
  The Lancet, 2009
• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
  New England Journal of Medicine, 2008